Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sqz Biotechnologies Company
(NY:
SQZ
)
N/A
UNCHANGED
Last Price
Updated: 5:00 PM EDT, Jul 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Sqz Biotechnologies Company
< Previous
1
2
3
Next >
SQZ Biotechnologies to Present at Upcoming Investor Conferences
April 06, 2022
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Publishes Comprehensive Preclinical Research on SQZ® TAC Platform’s Ability to Induce Multiple Key Mechanisms of Antigen-Specific Tolerance and Protect Against Type 1 Diabetes
April 04, 2022
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Announces $2 Million Grant From the National Institutes of Health to Develop a Novel, Scalable Cell Replacement Therapy for Parkinson’s Disease
March 21, 2022
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Reports Full Year 2021 Financial Results and Recent Portfolio Updates
March 16, 2022
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Announces Publication of Comprehensive Preclinical Research on SQZ® APC’s Ability to Overcome Fundamental Biological Barrier to Effective and Efficient Killer T Cell Activation
February 01, 2022
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Announces FDA Clearance of Investigational New Drug (IND) Application for SQZ-eAPC-HPV, a Novel mRNA-based Cell Therapy for the Treatment of HPV16 Positive Solid Tumors
January 24, 2022
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Announces Healthcare Industry Leader John Maraganore, Ph.D. Joining as Strategic Advisor
January 06, 2022
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Announces Lead Cell Therapy Candidate Induced Radiographic, Symptomatic and Immune Response as Monotherapy in Post-Checkpoint HPV+ Solid Tumor Patient
December 09, 2021
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotechnologies Lead Cell Therapy Candidate Generated Monotherapy Clinical Response Correlated with Substantial CD8 T Cell Tumor Infiltration in HPV+ Solid Tumor at Highest Dose
December 02, 2021
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotechnologies Announces Acceptance by Roche Accelerator in China
December 01, 2021
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotechnologies to Present at the 4th Annual Evercore ISI HealthCONx Conference
November 29, 2021
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies to Present at the Stifel 2021 Virtual Healthcare Conference
November 15, 2021
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotechnologies Presents New AAC, eAPC Platform Research and First Enhanced Tumor Infiltrating Lymphocyte Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting
November 12, 2021
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Reports Third Quarter 2021 Financial Results and Recent Portfolio Updates
November 10, 2021
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotechnologies Announces Independent DSMB Recommendation to Advance Lead Cell Therapy Candidate Into Combination With Checkpoint Inhibitors
October 26, 2021
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies to Present New Data at the Society for Immunotherapy of Cancer Annual Meeting
October 04, 2021
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies to Present at the Chardan 5th Annual Genetic Medicines Conference
September 30, 2021
From
SQZ Biotechnologies
Via
Business Wire
Illumina Ventures Closes $325 Million Fund Supporting Start-ups in Healthcare Innovation
September 29, 2021
SOURCE: Illumina
Via
3BL Media
SQZ Biotechnologies to Present at Cantor Global Healthcare Conference
September 27, 2021
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Announces First Autoimmune Disease Indication for Tolerizing Antigen Carrier (TAC) Platform
September 13, 2021
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies to Present at Upcoming Health Care Conferences
September 09, 2021
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Reports Second Quarter 2021 Financial Results and Recent Portfolio Updates
August 04, 2021
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience
July 01, 2021
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Presents Regenerative Medicine Data Demonstrating Neuron Generation from Human Pluripotent Stem Cells with Single Delivery of mRNA Transcription Factor
June 23, 2021
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotechnologies Tolerizing Antigen Carrier (TAC) Program Induces Antigen-Specific Immune Tolerance in Preclinical Models Demonstrating Potential for Broad Applicability Across Autoimmune Diseases
June 09, 2021
From
SQZ Biotechnologies
Via
Business Wire
SQZ Biotechnologies Initial First-In-Human Data Demonstrates Investigational Cell Therapy is Safe and Can Stimulate Immune Responses in Certain Patients with Advanced or Metastatic HPV16+ Tumors
June 04, 2021
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotech to Present at Jefferies Virtual Health Care Conference
May 27, 2021
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotechnologies to Present First Clinical Data at the American Society of Clinical Oncology Annual Meeting from Ongoing Phase 1 Study in Patients with Advanced or Metastatic HPV+ Tumors
May 19, 2021
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights
May 11, 2021
From
SQZ Biotechnologies Company
Via
Business Wire
SQZ Biotech to Present at BofA Securities 2021 Virtual Health Care Conference
May 05, 2021
From
SQZ Biotechnologies
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.